Women are far more susceptible to dangerous risk factors and mortality following aortic valve replacement (AVR) procedures, according to a study newly published in the Journal of the American Heart Association.

New research published in the Journal of the American College of Cardiology: Cardiovascular Interventions provides insight into the modern world of bioresorbable stents, while trying to explain why they’ve failed more often than traditional drug-eluting counterparts.

New research from the American Diabetes Association advises controlling symptoms of type 2 diabetes, including hyperglycemia and blood pressure control, may help prevent the decline of cognitive performance associated with the disease.

Medtronic has announced a new study to evaluate its next-generation transcatheter aortic valve replacement (TAVR) system in everyday clinical practice. The self-expanding CoreValve Evolut PRO valve was recently approved for commercial use in Europe and the United States.

Nicotine in electronic cigarettes boosts the cardiac adrenaline levels of users, which could put them at increased risk for heart disease, according to a new study in the Journal of the American Heart Association.

Although coronary heart disease (CHD) and peripheral arterial disease (PAD) share a handful of characteristics and risk factors, they affect different vascular territories and vary in pathogenesis, a study of more than two decades has found.

A new approach to treating symptomatic sinus bradycardia (SB) led to increased heart rate and improved quality of life in a single-center study of 62 patients, particularly those under the age of 50.

Boston Scientific (NYSE: BSX) today announced new data from the Multisensor Chronic Evaluation in Ambulatory Heart Failure Patients (MultiSENSE) study evaluating the performance of the HeartLogic™ Heart Failure Diagnostic to predict impending heart failure (HF) decompensation.